REFERENCES
1. Hempel A, Pagnamenta AT, Blyth M, et al. DDD Collaboration. deletions and de novo mutations of sox11 are associated with a neurodevelopmental disorder with features of coffin-siris syndrome. J Med Genet 2016;53:152-62.
2. Al-Naama N, Mackeh R, Kino T. C2H2-type zinc finger proteins in brain development, neurodevelopmental, and other neuropsychiatric disorders: systematic literature-based analysis. Front Neurol 2020;11:32.
3. Zhang K, Yu F, Zhu J, et al. Imbalance of excitatory/inhibitory neuron differentiation in neurodevelopmental disorders with an NR2F1 point mutation. Cell Rep 2020;31:107521.
4. Blok L, Rousseau J, Twist J, et al; DDD study. CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Nat Commun 2018;9:4619.
5. Yasin H, Gibson WT, Langlois S, et al. A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8. J Hum Genet 2019;64:271-80.
7. Mossink B, Negwer M, Schubert D, Nadif Kasri N. The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective. Cell Mol Life Sci 2021;78:2517-63.
8. Birkhoff JC, Huylebroeck D, Conidi A. ZEB2, the Mowat-Wilson syndrome transcription factor: confirmations, novel functions, and continuing surprises. Genes (Basel) 2021;12:1037.
9. Teixeira JR, Szeto RA, Carvalho VMA, Muotri AR, Papes F. Transcription factor 4 and its association with psychiatric disorders. Transl Psychiatry 2021;11:19.
10. Chen ES, Gigek CO, Rosenfeld JA, et al. Molecular convergence of neurodevelopmental disorders. Am J Hum Genet 2014;95:490-508.
11. Sugathan A, Biagioli M, Golzio C, et al. CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors. Proc Natl Acad Sci U S A 2014;111:E4468-77.
12. Engelen E, Akinci U, Bryne JC, et al. Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. Nat Genet 2011;43:607-11.
13. Maussion G, Diallo AB, Gigek CO, et al. Investigation of genes important in neurodevelopment disorders in adult human brain. Hum Genet 2015;134:1037-53.
14. Moen MJ, Adams HH, Brandsma JH, et al. An interaction network of mental disorder proteins in neural stem cells. Transl Psychiatry 2017;7:e1082.
15. Estruch SB, Graham SA, Quevedo M, et al. Proteomic analysis of FOXP proteins reveals interactions between cortical transcription factors associated with neurodevelopmental disorders. Hum Mol Genet 2018; doi: 10.1093/hmg/ddy035.
16. Gabriele M, Lopez Tobon A, D’Agostino G, Testa G. The chromatin basis of neurodevelopmental disorders: Rethinking dysfunction along the molecular and temporal axes. Prog Neuropsychopharmacol Biol Psychiatry 2018;84:306-27.
17. Lewis EM, Kroll KL. Development and disease in a dish: the epigenetics of neurodevelopmental disorders. Epigenomics 2018;10:219-31.
18. Fallah MS, Szarics D, Robson CM, Eubanks JH. Impaired regulation of histone methylation and acetylation underlies specific neurodevelopmental disorders. Front Genet 2020;11:613098.
19. Cogné B, Ehresmann S, Beauregard-Lacroix E, et al. CAUSES Study; Deciphering Developmental Disorders study. Missense variants in the histone acetyltransferase complex component gene TRRAP cause autism and syndromic intellectual disability. Am J Hum Genet 2019;104:530-41.
20. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. Embryonic stem cells express neuronal properties in vitro. Dev Biol 1995;168:342-57.
21. Okabe S, Forsberg-nilsson K, Spiro AC, Segal M, Mckay RD. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mechanisms of Development 1996;59:89-102.
22. Zhang SC, Wernig M, Duncan ID, Brüstle O, Thomson JA. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001;19:1129-33.
23. Ying QL, Stavridis M, Griffiths D, Li M, Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 2003;21:183-6.
24. Peljto M, Wichterle H. Programming embryonic stem cells to neuronal subtypes. Curr Opin Neurobiol 2011;21:43-51.
25. Eiraku M, Sasai Y. Self-formation of layered neural structures in three-dimensional culture of ES cells. Curr Opin Neurobiol 2012;22:768-77.
26. Lancaster MA, Knoblich JA. Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc 2014;9:2329-40.
27. Zhang M, Ngo J, Pirozzi F, Sun YP, Wynshaw-Boris A. Highly efficient methods to obtain homogeneous dorsal neural progenitor cells from human and mouse embryonic stem cells and induced pluripotent stem cells. Stem Cell Res Ther 2018;9:67.
28. Galiakberova AA, Dashinimaev EB. Neural stem cells and methods for their generation from induced pluripotent stem cells. in vitro ;8:815.
30. Doostparast Torshizi A, Armoskus C, Zhang H, et al. Deconvolution of transcriptional networks identifies TCF4 as a master regulator in schizophrenia. Sci Adv 2019;5:eaau4139.
31. Dries R, Stryjewska A, Coddens K, et al. Integrative and perturbation-based analysis of the transcriptional dynamics of TGFβ/BMP system components in transition from embryonic stem cells to neural progenitors. Stem Cells 2020;38:202-17.
32. Verschueren K, Remacle JE, Collart C, et al. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5’-CACCT sequences in candidate target genes. J Biol Chem 1999;274:20489-98.
33. Mowat DR, Croaker GD, Cass DT, et al. Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23. J Med Genet 1998;35:617-23.
34. Cacheux V, Dastot-Le Moal F, Kääriäinen H, et al. Loss-of-function mutations in SIP1 Smad interacting protein 1 result in a syndromic Hirschsprung disease. Hum Mol Genet 2001;10:1503-10.
35. Wakamatsu N, Yamada Y, Yamada K, et al. Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nat Genet 2001;27:369-70.
37. Mainardi P, Pastore G, Zweier C, Rauch A. Mowat-Wilson syndrome and mutation in the zinc finger homeo box 1B gene: a well defined clinical entity. J Med Genet 2004;41:e16.
38. Ishihara N, Yamada K, Yamada Y, et al. Clinical and molecular analysis of Mowat-Wilson syndrome associated with ZFHX1B mutations and deletions at 2q22-q24.1. J Med Genet 2004;41:387-93.
39. Yamada K, Yamada Y, Nomura N, et al. Nonsense and frameshift mutations in ZFHX1B, encoding Smad-interacting protein 1, cause a complex developmental disorder with a great variety of clinical features. Am J Hum Genet 2001;69:1178-85.
40. Wilson M, Mowat D, Dastot-Le Moal F, et al. Further delineation of the phenotype associated with heterozygous mutations in ZFHX1B. Am J Med Genet A 2003;119A:257-65.
41. Zweier C, Thiel CT, Dufke A, et al. Clinical and mutational spectrum of Mowat-Wilson syndrome. Eur J Med Genet 2005;48:97-111.
42. Zweier C, Horn D, Kraus C, Rauch A. Atypical ZFHX1B mutation associated with a mild Mowat-Wilson syndrome phenotype. Am J Med Genet A 2006;140:869-72.
43. Garavelli L, Zollino M, Mainardi PC, et al. Mowat-Wilson syndrome: facial phenotype changing with age: study of 19 Italian patients and review of the literature. Am J Med Genet A 2009;149A:417-26.
44. Ivanovski I, Djuric O, Caraffi SG, et al. Phenotype and genotype of 87 patients with Mowat-Wilson syndrome and recommendations for care. Genet Med 2018;20:965-75.
45. Garavelli L, Ivanovski I, Caraffi SG, et al. Neuroimaging findings in Mowat-Wilson syndrome: a study of 54 patients. Genet Med 2017;19:691-700.
46. Ricci E, Fetta A, Garavelli L, et al. Mowat Wilson Epilepsy Study Group. Further delineation and long-term evolution of electroclinical phenotype in Mowat Wilson Syndrome. A longitudinal study in 40 individuals. Epilepsy Behav 2021;124:108315.
47. Dastot-Le Moal F, Wilson M, Mowat D, et al. ZFHX1B mutations in patients with Mowat-Wilson syndrome. Hum Mutat 2007;28:313-21.
48. Heinritz W, Zweier C, Froster UG, et al. A missense mutation in the ZFHX1B gene associated with an atypical Mowat-Wilson syndrome phenotype. Am J Med Genet A 2006;140:1223-7.
49. Ghoumid J, Drevillon L, Alavi-Naini SM, et al. ZEB2 zinc-finger missense mutations lead to hypomorphic alleles and a mild Mowat-Wilson syndrome. Hum Mol Genet 2013;22:2652-61.
50. Verstappen G, van Grunsven LA, Michiels C, et al. Atypical Mowat-Wilson patient confirms the importance of the novel association between ZFHX1B/SIP1 and NuRD corepressor complex. Hum Mol Genet 2008;17:1175-83.
51. Wu LM, Wang J, Conidi A, et al. Zeb2 recruits HDAC-NuRD to inhibit notch and controls Schwann cell differentiation and remyelination. Nat Neurosci 2016;19:1060-72.
52. Birkhoff JC, Brouwer RWW, Kolovos P, et al. Targeted chromatin conformation analysis identifies novel distal neural enhancers of ZEB2 in pluripotent stem cell differentiation. Hum Mol Genet 2020;29:2535-50.
53. Huang X, Ferris ST, Kim S, et al. Differential usage of transcriptional repressor Zeb2 enhancers distinguishes adult and embryonic hematopoiesis. Immunity 2021;54:1417-1432.e7.
54. Pitt D, Hopkins I. A syndrome of mental retardation, wide mouth and intermittent overbreathing. Aust Paediatr J 1978;14:182-4.
55. Amiel J, Rio M, de Pontual L, et al. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet 2007;80:988-93.
56. Brockschmidt A, Todt U, Ryu S, et al. Severe mental retardation with breathing abnormalities (Pitt-Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4. Hum Mol Genet 2007;16:1488-94.
57. Zweier C, Peippo MM, Hoyer J, et al. Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 2007;80:994-1001.
58. Marangi G, Zollino M. Pitt-Hopkins Syndrome and Differential Diagnosis: a Molecular and Clinical Challenge. J Pediatr Genet 2015;4:168-76.
59. Whalen S, Héron D, Gaillon T, et al. Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum. Hum Mutat 2012;33:64-72.
60. Fierro JA, Avina DA. Pitt-Hopkins syndrome: mental retardation, psychomotor and developmental delays with facial dysmorphism. J Pediatr Genet 2014;3:141-5.
61. Mary L, Piton A, Schaefer E, et al. Disease-causing variants in TCF4 are a frequent cause of intellectual disability: lessons from large-scale sequencing approaches in diagnosis. Eur J Hum Genet 2018;26:996-1006.
62. Goodspeed K, Newsom C, Morris MA, et al. Pitt-Hopkins syndrome: a review of current literature, clinical approach, and 23-patient case series. J Child Neurol 2018;33:233-44.
63. Remacle JE, Kraft H, Lerchner W, et al. New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J 1999;18:5073-84.
64. Birkhoff JC, Korporaal AL, Brouwer RWW, et al. Zeb2 DNA-binding sites in ES cell derived neuroprogenitor cells reveal autoregulation and align with neurodevelopmental knockout mouse and disease phenotypes. bioRχiv 2021; doi: 10.1101/2021.07.06.451350.
65. Murre C, Mccaw PS, Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MYOD, and MYC proteins. Cell 1989;56:777-83.
66. Conidi A, van den Berghe V, Leslie K, et al. Four amino acids within a tandem QxVx repeat in a predicted extended α-helix of the Smad-binding domain of Sip1 are necessary for binding to activated Smad proteins. PLoS One 2013;8:e76733.
67. Sepp M, Kannike K, Eesmaa A, Urb M, Timmusk T. Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5’ exon usage and splicing. PLoS One 2011;6:e22138.
68. Nurm K, Sepp M, Castany-Pladevall C, et al. Isoform-Specific Reduction of the Basic Helix-Loop-Helix Transcription Factor TCF4 Levels in Huntington’s Disease. eNeuro 2021;8:ENEURO.
69. Chen HY, Bohlen JF, Maher BJ. Molecular and cellular function of transcription factor 4 in Pitt-Hopkins syndrome. Dev Neurosci 2021;43:159-67.
70. Maduro V, Pusey BN, Cherukuri PF, et al. Complex translocation disrupting TCF4 and altering TCF4 isoform expression segregates as mild autosomal dominant intellectual disability. Orphanet J Rare Dis 2016;11:62.
71. Bedeschi MF, Marangi G, Calvello MR, et al. Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4. Eur J Med Genet 2017;60:565-71.
72. Forrest M, Chapman RM, Doyle AM, et al. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome. Hum Mutat 2012;33:1676-86.
73. Wang LH, Baker NE. E proteins and ID proteins: helix-loop-helix partners in development and disease. Dev Cell 2015;35:269-80.
74. Yang J, Horton JR, Li J, et al. Structural basis for preferential binding of human TCF4 to DNA containing 5-carboxylcytosine. Nucleic Acids Res 2019;47:8375-87.
75. Massari ME, Grant PA, Pray-grant MG, et al. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Molecular Cell 1999;4:63-73.
76. Bayly R, Chuen L, Currie RA, et al. E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells. J Biol Chem 2004;279:55362-71.
77. Zhang J, Kalkum M, Yamamura S, Chait BT, Roeder RG. E protein silencing by the leukemogenic AML1-ETO fusion protein. Science 2004;305:1286-9.
78. Quevedo M, Meert L, Dekker MR, et al. Mediator complex interaction partners organize the transcriptional network that defines neural stem cells. Nat Commun 2019;10:2669.
79. van den Berghe V, Stappers E, Vandesande B, et al. Directed migration of cortical interneurons depends on the cell-autonomous action of Sip1. Neuron 2013;77:70-82.
80. Stryjewska A, Dries R, Pieters T, et al. Zeb2 regulates cell fate at the exit from epiblast state in mouse embryonic stem cells. Stem Cells 2017;35:611-25.
81. van Helden MJ, Goossens S, Daussy C, et al. Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection. J Exp Med 2015;212:2015-25.
82. Wang J, Farkas C, Benyoucef A, et al. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity. PLoS Biol 2021;19:e3001394.
83. Dowen JM, Fan ZP, Hnisz D, et al. Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes. Cell 2014;159:374-87.
84. Benito-Kwiecinski S, Giandomenico SL, Sutcliffe M, et al. An early cell shape transition drives evolutionary expansion of the human forebrain. Cell 2021;184:2084-2102.e19.
85. Kim H, Berens NC, Ochandarena NE, Philpot BD. Region and cell type distribution of TCF4 in the postnatal mouse brain. Front Neuroanat 2020;14:42.
86. Lennertz L, Rujescu D, Wagner M, et al. Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients. Neuropsychobiology 2011;63:131-6.
87. Quednow BB, Ettinger U, Mössner R, et al. The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J Neurosci 2011;31:6684-91.
88. Jung M, Häberle BM, Tschaikowsky T, et al. Analysis of the expression pattern of the schizophrenia-risk and intellectual disability gene TCF4 in the developing and adult brain suggests a role in development and plasticity of cortical and hippocampal neurons. Mol Autism 2018;9:20.
89. Sripathy SR, Wang Y, Moses RL, et al. Generation of 10 patient-specific induced pluripotent stem cells (iPSCs) to model Pitt-Hopkins syndrome. Stem Cell Res 2020;48:102001.
90. Gheldof A, Hulpiau P, van Roy F, De Craene B, Berx G. Evolutionary functional analysis and molecular regulation of the ZEB transcription factors. Cell Mol Life Sci 2012;69:2527-41.
91. Hegarty SV, Sullivan AM, O’Keeffe GW. Zeb2: a multifunctional regulator of nervous system development. Prog Neurobiol 2015;132:81-95.
92. Epifanova E, Babaev A, Newman AG, Tarabykin V. Role of Zeb2/Sip1 in neuronal development. Brain Res 2019;1705:24-31.
93. Scott CL, Omilusik KD. ZEBs: novel players in immune cell development and function. Trends Immunol 2019;40:431-46.
94. Higashi Y, Maruhashi M, Nelles L, et al. Generation of the floxed allele of the SIP1 (Smad-interacting protein 1) gene for Cre-mediated conditional knockout in the mouse. Genesis 2002;32:82-4.
95. Seuntjens E, Nityanandam A, Miquelajauregui A, et al. Sip1 regulates sequential fate decisions by feedback signaling from postmitotic neurons to progenitors. Nat Neurosci 2009;12:1373-80.
96. McKinsey GL, Lindtner S, Trzcinski B, et al. Dlx1&2-dependent expression of Zfhx1b (Sip1, Zeb2) regulates the fate switch between cortical and striatal interneurons. Neuron 2013;77:83-98.
97. Deryckere A, Stappers E, Dries R, et al. Multifaceted actions of Zeb2 in postnatal neurogenesis from the ventricular-subventricular zone to the olfactory bulb. Development 2020;147:dev184861.
98. Vivinetto AL, Kim ID, Goldberg DC, et al. Zeb2 is a regulator of astrogliosis and functional recovery after CNS injury. Cell Rep 2020;31:107834.
99. Quintes S, Brinkmann BG, Ebert M, et al. Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair. Nat Neurosci 2016;19:1050-9.
100. Boland BS, He Z, Tsai MS, et al. Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses. Sci Immunol 2020;5:eabb4432.
101. Gladka MM, Kohela A, Molenaar B, et al. Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner. Nat Commun 2021;12:84.
102. de Haan W, Dheedene W, Apelt K, et al. Endothelial Zeb2 preserves the hepatic angioarchitecture and protects against liver fibrosis. Cardiovasc Res 2022;118:1262-75.
103. Vandamme N, Denecker G, Bruneel K, et al. The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype. Cancer Res 2020;80:2983-95.
104. Turovskaya MV, Babaev AA, Zinchenko VP, et al. Sip-1 mutations cause disturbances in the activity of NMDA- and AMPA-, but not kainate receptors of neurons in the cerebral cortex. Neurosci Lett 2017;650:180-6.
105. Jeub M, Emrich M, Pradier B, et al. The transcription factor Smad-interacting protein 1 controls pain sensitivity via modulation of DRG neuron excitability. Pain 2011;152:2384-98.
106. Pradier B, Jeub M, Markert A, et al. Smad-interacting protein 1 affects acute and tonic, but not chronic pain. Eur J Pain 2014;18:249-57.
107. Khan RAW, Chen J, Wang M, et al. A new risk locus in the ZEB2 gene for schizophrenia in the Han Chinese population. Prog Neuropsychopharmacol Biol Psychiatry 2016;66:97-103.
108. Takagi T, Nishizaki Y, Matsui F, Wakamatsu N, Higashi Y. De novo inbred heterozygous Zeb2/Sip1 mutant mice uniquely generated by germ-line conditional knockout exhibit craniofacial, callosal and behavioral defects associated with Mowat-Wilson syndrome. Hum Mol Genet 2015;24:6390-402.
109. Rannals MD, Maher BJ. Molecular mechanisms of transcription factor 4 in Pitt hopkins syndrome. Curr Genet Med Rep 2017;5:1-7.
110. Braun K, Häberle BM, Wittmann MT, Lie DC. Enriched environment ameliorates adult hippocampal neurogenesis deficits in Tcf4 haploinsufficient mice. BMC Neurosci 2020;21:50.
111. Praag H, Kempermann G, Gage FH. Neural consequences of environmental enrichment. Nat Rev Neurosci 2000;1:191-8.
112. Kennedy AJ, Rahn EJ, Paulukaitis BS, et al. Tcf4 regulates synaptic plasticity, DNA methylation, and memory function. Cell Rep 2016;16:2666-85.
113. Sepp M, Pruunsild P, Timmusk T. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects. Hum Mol Genet 2012;21:2873-88.
114. Flora A, Garcia JJ, Thaller C, Zoghbi HY. The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors. Proc Natl Acad Sci U S A 2007;104:15382-7.
115. Fischer B, Azim K, Hurtado-Chong A, et al. E-proteins orchestrate the progression of neural stem cell differentiation in the postnatal forebrain. Neural Dev 2014;9:23.
116. Li H, Zhu Y, Morozov YM, et al. Disruption of TCF4 regulatory networks leads to abnormal cortical development and mental disabilities. Mol Psychiatry 2019;24:1235-46.
117. Mesman S, Bakker R, Smidt MP. Tcf4 is required for correct brain development during embryogenesis. Mol Cell Neurosci 2020;106:103502.
118. Thaxton C, Kloth AD, Clark EP, et al. Common pathophysiology in multiple mouse models of Pitt-Hopkins syndrome. J Neurosci 2018;38:918-36.
119. Schoof M, Hellwig M, Harrison L, et al. The basic helix-loop-helix transcription factor TCF4 impacts brain architecture as well as neuronal morphology and differentiation. Eur J Neurosci 2020;51:2219-35.
120. Phan BN, Bohlen JF, Davis BA, et al. A myelin-related transcriptomic profile is shared by Pitt-Hopkins syndrome models and human autism spectrum disorder. Nat Neurosci 2020;23:375-85.
121. Weng Q, Chen Y, Wang H, et al. Dual-mode modulation of Smad signaling by Smad-interacting protein Sip1 is required for myelination in the central nervous system. Neuron 2012;73:713-28.
122. Zhang Y, Cai Y, Wang Y, et al. Survival control of oligodendrocyte progenitor cells requires the transcription factor 4 during olfactory bulb development. Cell Death Dis 2021;12:91.
123. Cisse B, Caton ML, Lehner M, et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008;135:37-48.
124. Hill MJ, Killick R, Navarrete K, et al. Knockdown of the schizophrenia susceptibility gene. TCF4 ;42:181-8.
125. Forrest MP, Waite AJ, Martin-Rendon E, Blake DJ. Knockdown of human TCF4 affects multiple signaling pathways involved in cell survival, epithelial to mesenchymal transition and neuronal differentiation. PLoS One 2013;8:e73169.
126. Chen T, Wu Q, Zhang Y, et al. Tcf4 controls neuronal migration of the cerebral cortex through regulation of bmp7. Front Mol Neurosci 2016;9:94.
128. Kloet SL, Baymaz HI, Makowski M, et al. Towards elucidating the stability, dynamics and architecture of the nucleosome remodeling and deacetylase complex by using quantitative interaction proteomics. FEBS J 2015;282:1774-85.
129. Torchy MP, Hamiche A, Klaholz BP. Structure and function insights into the NuRD chromatin remodeling complex. Cell Mol Life Sci 2015;72:2491-507.
130. Fröb F, Wegner M. The role of chromatin remodeling complexes in Schwann cell development. Glia 2020;68:1596-603.
131. D’Souza L, Channakkar AS, Muralidharan B. Chromatin remodelling complexes in cerebral cortex development and neurodevelopmental disorders. Neurochem Int 2021;147:105055.
132. Benayoun BA, Pollina EA, Ucar D, et al. H3K4me3 breadth is linked to cell identity and transcriptional consistency. Cell 2014;158:673-88.
133. Chen K, Chen Z, Wu D, et al. Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes. Nat Genet 2015;47:1149-57.
134. Miquelajauregui A, Van de Putte T, Polyakov A, et al. Smad-interacting protein-1 (Zfhx1b) acts upstream of Wnt signaling in the mouse hippocampus and controls its formation. Proc Natl Acad Sci U S A 2007;104:12919-24.
135. Kotter MR, Stadelmann C, Hartung HP. Enhancing remyelination in disease-can we wrap it up? Brain 2011;134:1882-900.
136. de Putte T, Francis A, Nelles L, van Grunsven LA, Huylebroeck D. Neural crest-specific removal of Zfhx1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome. Hum Mol Genet 2007;16:1423-36.
137. Szu J, Wojcinski A, Jiang P, Kesari S. Impact of the Olig Family on Neurodevelopmental Disorders. Front Neurosci 2021;15:659601.
138. Hennig KM, Fass DM, Zhao WN, et al. WNT/β-catenin pathway and epigenetic mechanisms regulate the pitt-hopkins syndrome and schizophrenia risk gene. TCF4 ;3:53-71.
139. Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J 2021;40:e108647.
